GLP-1RA and the risk of non-arteritic anterior ischaemic optic neuropathy in patients with type 2 diabetes: A population-based study. [PDF]
Tesfaye H +7 more
europepmc +1 more source
GLP-1RA and SGLT2i utilization in people with type 2 diabetes with atherosclerotic cardiovascular disease (ASCVD) or at high risk of ASCVD in the Gulf Region [PDF]
Waleed A. Al-Dahi +12 more
openalex +1 more source
IL-27, a metabolic regulator secreted by astrocytes in response to GLP-1RA OHP2, modulates microglial reprogramming in Alzheimer's disease by regulating cGAS lactylation. [PDF]
Du Y, Wu L, Mao Y, Chen S, Gao X.
europepmc +1 more source
Impact of SGLT2i and GLP-1RA on liver-related events in patients with MASLD and type 2 diabetes: A network meta-analysis. [PDF]
Li L +8 more
europepmc +1 more source
Exploring the risk of depression and suicide/self-injury in patients receiving GLP-1RAs combined with metformin versus GLP-1RA monotherapy: a real-word analysis of the FAERS database. [PDF]
Ji W, Ma Y, Fang J, Chen L.
europepmc +1 more source
The Role of GLP-1RA Medications in Medical Weight Loss and the Positive Impacts on Lipid Management [PDF]
Blair Suter +4 more
openalex +1 more source
Comparative Effectiveness of SGLT2i and GLP-1RA on Blood Pressure in Hypertensive Patients with Type 2 Diabetes: A Saudi Multicenter Retrospective Study. [PDF]
Alshehri G +9 more
europepmc +1 more source
Navigating Sarcopenia Risks in GLP-1RA Therapy for Advanced Heart Failure. [PDF]
Wang W +12 more
europepmc +1 more source

